Both in Pharmaceuticals
Vistagen Therapeutics vs Lexaria Bioscience
Over the past year VTGN returned −95.5% and LEXX returned −76.3%; their daily moves had a correlation of 0.03.
VTGN −95.5% LEXX −76.3%Growth of $1, one year, split-adjusted
| Metric | VTGN | LEXX |
|---|---|---|
| Price | $0.1683 | $3.49 |
| Market cap | $7.5M | $7.4M |
| Today | −1.41% | −7.43% |
| 1 month | −40.4% | +12.9% |
| 6 months | −73.1% | −67.3% |
| Year to date | −74.6% | −62.3% |
| 1 year | −95.8% | −75.7% |
| Revenue growth (YoY) | +504.9% | −100.0% |
| Gross margin | 100.0% | — |
| Net margin | −882.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.0× | 37.9× |
| Net cash | $31.7M | $3.6M |
| Dividend yield | — | — |
| Volatility (60d) | 106.5% | 194.3% |
| Short % of float | 5.7% | 16.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).